These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7839447)

  • 1. Central nervous system lymphomas in organ allograft recipients.
    Penn I; Porat G
    Transplantation; 1995 Jan; 59(2):240-4. PubMed ID: 7839447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P; Giglio P
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
    Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
    Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
    Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary central nervous system lymphoma. Results at the University of California at Los Angeles and review of the literature.
    Selch MT; Shimizu KT; De Salles AF; Sutton C; Parker RG
    Am J Clin Oncol; 1994 Aug; 17(4):286-93. PubMed ID: 8048389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?
    Restrepo A; Raez LE; Byrne GE; Johnson T; Ossi P; Benedetto P; Hamilton K; Whitcomb CC; Cassileth PA
    Crit Rev Oncog; 1998; 9(3-4):269-73. PubMed ID: 10201631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary central nervous system lymphoma.
    Gerstner ER; Batchelor TT
    Arch Neurol; 2010 Mar; 67(3):291-7. PubMed ID: 20212226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
    Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
    Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary central nervous system posttransplant lymphoproliferative disorders.
    Castellano-Sanchez AA; Li S; Qian J; Lagoo A; Weir E; Brat DJ
    Am J Clin Pathol; 2004 Feb; 121(2):246-53. PubMed ID: 14983939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature.
    Yoshihara T; Morimoto A; Kuroda H; Imamura T; Ishida H; Tsunamoto K; Naya M; Hibi S; Todo S; Imashuku S
    Bone Marrow Transplant; 2006 Jan; 37(1):25-31. PubMed ID: 16247416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
    Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
    Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment results and the prognosis in patients with localization of non-Hodgkins-lymphoma in the central nervous system].
    Paulus JA; Bos GM; Löwenberg B; Van Den Bent MJ
    Ned Tijdschr Geneeskd; 1998 Oct; 142(40):2196-200. PubMed ID: 9864481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.
    Blaes AH; Peterson BA; Bartlett N; Dunn DL; Morrison VA
    Cancer; 2005 Oct; 104(8):1661-7. PubMed ID: 16149091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplantation lymphoproliferative disorder involving the central nervous system in liver transplant recipients.
    Xu QS; Ye S; Zhou YQ; Sheng JF; Ye K; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):551-4. PubMed ID: 18842507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.
    Tomita N; Kodama F; Kanamori H; Motomura S; Ishigatsubo Y
    Cancer; 2002 Aug; 95(3):576-80. PubMed ID: 12209750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Melanoma in organ transplant patients].
    Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
    Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome.
    Ustun C; Reid-Nicholson M; Nayak-Kapoor A; Jones-Crawford J; McDonald K; Jillella AP; Ramalingam P
    Ann Hematol; 2009 Apr; 88(4):351-8. PubMed ID: 18787825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system.
    Jahnke K; Thiel E; Martus P; Schwartz S; Korfel A
    Ann Hematol; 2006 Jan; 85(1):45-50. PubMed ID: 16132909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.